Yuka Takemon
Yuka Takemon
PhD candidate, Canada's Michael Smith Genome Science Centre, BC Cancer
Verified email at bcgsc.ca - Homepage
Title
Cited by
Cited by
Year
FAR2 is associated with kidney disease in mice and humans
G Backer, S Eddy, SM Sheehan, Y Takemon, A Reznichenko, HS Savage, ...
Physiological genomics 50 (8), 543-552, 2018
82018
Whole-genome sequence of the C57L/J mouse inbred strain
G Ananda, Y Takemon, D Hinerfeld, R Korstanje
G3: Genes, Genomes, Genetics 4 (9), 1689-1692, 2014
62014
Proteomic and transcriptomic profiling reveal different aspects of aging in the kidney
Y Takemon, JM Chick, IG Gyuricza, DA Skelly, O Devuyst, SP Gygi, ...
Elife 10, e62585, 2021
42021
Uncovering Modifier Genes of X-Linked Alport Syndrome Using a Novel Multiparent Mouse Model
Y Takemon, V Wright, B Davenport, DM Gatti, SM Sheehan, K Letson, ...
Journal of the American Society of Nephrology 32 (8), 1961-1973, 2021
22021
Linked-read sequencing analysis reveals tumor-specific genome variation landscapes in neurofibromatosis type 2 (NF2) patients
DS Roberts, R Maurya, Y Takemon, J Vitte, L Gong, J Zhao, CH Wong, ...
Otology & Neurotology 40 (2), e150-e159, 2019
22019
Functional Characterization of Lipid Regulatory Effects of Three Genes Using Knockout Mouse Models
C Yao, H Savage, T Hao, GY Lee, Y Takemon, W Bian, DE Hill, M Vidal, ...
medRxiv, 2021
2021
Investigating aspartoacylase activity in mouse podocytes through genomic and proteomic analyses.
Y Takemon
2013
The system can't perform the operation now. Try again later.
Articles 1–7